NITD008 suppressed the replication of different strains of HCV.
The resistance to NITD008 was conferred by mutation in NS5B (S282T).
The resistance pattern of NITD008 was not completely similar to Sofosbuvir.
NITD008 displayed significant synergistic effects with Sofosbuvir.